alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
IV 

111TH CONGRESS 

2D SESSION H. RES. 1601 

Recognizing that the religious freedom and human rights violations of 

Kashmiri Pandits has been ongoing since 1989. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 30, 2010 

Mr. PALLONE submitted the following resolution; which was referred to the 

Committee on Foreign Affairs 

RESOLUTION 

Recognizing that the religious freedom and human rights 

violations of Kashmiri Pandits has been ongoing since 1989. 

Whereas Jammu and Kashmir has an ancient culture of religious tolerance and pluralism, where Hindus, Muslims, 

Sikhs, Buddhists, and Christians practiced their faith 

freely in an atmosphere of mutual respect and peace until 

1989; 

Whereas Kashmiri Pandits are the original inhabitants of 

Kashmir, tracing their heritage and culture back several 

millennia; 

Whereas Kashmiri Pandits have been the victims of documented human rights violations resulting in the severe 

curtailment of their religious freedom for more than two 

decades; 


smartinez on DSKB9S0YB1PROD with BILLS
2 

•HRES 1601 IH 

Whereas the Kashmiri Pandit population has declined from 

400,000 in 1989 to a current level of less than 4,000 in 

the Kashmir valley and many Pandits continue to live in 

refugee camps; 

Whereas international human rights organizations have noted 

the campaign of intimidation and violence directed by 

foreign militants and foreign terrorist organizations 

against Kashmiri Pandits; 

Whereas thousands of Kashmiri Pandits, elected officials, and 

military personnel have been killed in terrorist attacks; 

and 

Whereas numerous groups that have claimed responsibility 

for these attacks have been designated as foreign terrorist organizations by the United States Department of 

State: Now, therefore, be it 

1 Resolved, That the House of Representatives— 

2 (1) condemns the extremist violence, lack of re3 ligious freedom, and human rights violations com4 mitted against Kashmiri Pandits, which they have 

5 endured for more than two decades; and 

6 (2) insists that terrorist infrastructure in the 

7 region must be dismantled and terrorists should be 

8 held accountable for their actions. 

Æ 


smartinez on DSKB9S0YB1PROD with BILLS
Michael RIVERS, petitioner, v. UNITED STATES.

No. 16-6533.

Supreme Court of the United States

Nov. 28, 2016.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
Paulino ZAVALA-GARCIA, petitioner, v. UNITED STATES.

No. 16-5996.

Supreme Court of the United States

Oct. 31, 2016.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
John D. ASHCROFT, former Attorney General, et al., petitioners, v. Ahmer Iqbal ABBASI, et al.

No. 15-1359.

Supreme Court of the United States

Jan. 6, 2017.

Motion of petitioners for enlargement of time for oral argument and for divided *616argument is granted in part and denied in part and the time is divided as follows: 20 minutes for the Acting Solicitor General on behalf of petitioners in Nos. 15-1358 and 15-1359, 10 minutes for petitioners in No. 15-1363, and 30 minutes for respondents.

Justice SOTOMAYOR and Justice KAGAN took no part in the consideration or decision of this motion.
BWP MEDIA USA, INC., dba Pacific Coast News, et al., petitioners, v. CLARITY DIGITAL GROUP, LLC, nka AXS Digital Media Group, LLC.

No. 16M41.

Supreme Court of the United States

Oct. 31, 2016.

Motion to direct the Clerk to file a petition for writ of certiorari out of time denied.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of State

          - [Public Notice 3705]

# AGENCY:

United States Department of State.

# ACTION:

Notice.

      ( print page 33287)    

# SUMMARY:

                        Notice is hereby given of the following determinations: Pursuant to the authority vested in me by the Act of October 19, 1965 (79 Stat. 985, 22 U.S.C. 2459), the Foreign Affairs Reform and Restructuring Act of 1998 (112 Stat. 2681                         *et seq.*), Delegation of Authority No. 234 of October 1, 1999 (64 FR 56014), and Delegation of Authority No. 236 of October 19, 1999 (64 FR 57920), as amended by Delegation of Authority No. 236-3 of August 28, 2000 (65 FR 53795), I hereby determine that the objects to be included in the exhibit, “Exploring the Holy Land: David Roberts and Beyond,” imported from abroad for the temporary exhibition without profit within the United States, are of cultural significance. The objects are imported pursuant to a loan agreement with a foreign lender. I also determine that the temporary exhibition or display of the objects at the Bowers Museum of Cultural Art, Santa Ana, California, from on or about October 6, 2001, to on or about January 9, 2002, and possible additional venues yet to be determined is in the national interest. Public Notice of these determinations is ordered to be published in the                         **Federal Register**                        .                    

# FOR FURTHER INFORMATION CONTACT:

For further information, including a list of the exhibit objects, contact Paul W. Manning, Attorney-Adviser, Office of the Legal Adviser, 202/619-5997, and the address is United States Department of State, SA-44, Room 700, 301 4th Street, SW., Washington, DC 20547-0001.

Dated: June 14, 2001.

Helena Kane Finn,

Acting Assistant Secretary for Educational and Cultural Affairs, United States Department of State.

[FR Doc. 01-15629 Filed 6-20-01; 8:45 am]

BILLING CODE 4710-08-P
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                         835,517
<SECURITIES>                                         0
<RECEIVABLES>                                1,594,801
<ALLOWANCES>                                    75,000
<INVENTORY>                                     21,723
<CURRENT-ASSETS>                             2,479,412
<PP&E>                                       1,041,461
<DEPRECIATION>                                 595,418
<TOTAL-ASSETS>                               4,129,422
<CURRENT-LIABILITIES>                        1,682,263
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           174
<OTHER-SE>                                   2,308,145
<TOTAL-LIABILITY-AND-EQUITY>                 4,129,422
<SALES>                                      3,496,131
<TOTAL-REVENUES>                             3,496,131
<CGS>                                        2,609,967
<TOTAL-COSTS>                                4,472,487
<OTHER-EXPENSES>                               (21,060)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                               (955,296)
<INCOME-TAX>                                  (955,296)
<INCOME-CONTINUING>                           (955,296)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (955,296)
<EPS-PRIMARY>                                    (0.58)
<EPS-DILUTED>                                        0
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE>      5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                          57,246
<SECURITIES>                                    20,164
<RECEIVABLES>                                    3,352
<ALLOWANCES>                                     (190)
<INVENTORY>                                          0
<CURRENT-ASSETS>                                81,425
<PP&E>                                          30,138
<DEPRECIATION>                                 (2,037)
<TOTAL-ASSETS>                                 167,897
<CURRENT-LIABILITIES>                           15,990
<BONDS>                                        131,965
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            19
<OTHER-SE>                                      19,577
<TOTAL-LIABILITY-AND-EQUITY>                   167,897
<SALES>                                          6,815
<TOTAL-REVENUES>                                 6,815
<CGS>                                            5,507
<TOTAL-COSTS>                                   11,147
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              10,652
<INCOME-PRETAX>                               (11,725)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (11,725)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (11,725)
<EPS-PRIMARY>                                   (0.61)
<EPS-DILUTED>                                        0
        

</TABLE>
<Page>

                                                                    Exhibit 24.1

                                POWER OF ATTORNEY

         KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned directors
(each, a "Signatory") of GenVec, Inc., a corporation organized under the laws of
the state of Delaware (the "Company"), hereby constitutes and appoints Paul H.
Fischer, Jeffrey W. Church and Richard E. Baltz (each, an "Agent", and
collectively, "Agents") or any of them, his true and lawful attorney-in-fact and
agent for and in his name, place and stead, in any and all capacities, to sign
the Company's Annual Report on Form 10-K for the year ended December 31, 2001
and to file the same, with all exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange Commission. Each
Signatory further grants to the Agents, and each of them, full power and
authority to do and perform each and every act and thing requisite and
necessary, in the judgment of such Agent, to be done in connection with any such
signing and filing, as full to all intents and purposes as he might or could do
in person, and hereby ratifies and confirms all that said Agents, or any of
them, may lawfully do or cause to be done by virtue hereof.

         This Power of Attorney may be executed simultaneously in one or more
counterparts, each of which shall be deemed an original, but all of which
constitute but one and the same instrument.

<Table>
<Caption>
            SIGNATURE                           TITLE                   DATE

<S>                              <C>                              <C>
/s/ Paul H. Fischer, PH.D.       Director, President and Chief    March 6, 2002
--------------------------       Executive Officer
Paul H. Fischer, Ph.D.


/s/ Jeffrey W. Church            Chief Financial Officer,         March 6, 2002
---------------------            Treasurer and Secretary
Jeffrey W. Church                (Principal Financial
                                 and Accounting Officer)

/s/ Herbert J. Conrad            Director                         March 6, 2002
---------------------
Herbert J. Conrad


/s/ Wayne T. Hockmeyer, PH.D.    Director                         March 6, 2002
-----------------------------
Wayne T. Hockmeyer, Ph.D.


/s/ John H. Landon               Director                         March 6, 2002
------------------
John H. Landon


/s/ Harry T. Rein                Director                         March 6, 2002
-----------------
Harry T. Rein
</Table>

<Page>

<Table>
<S>                              <C>                              <C>
/s/ Wendell Wierenga, PH.D.      Director                         March 6, 2002
---------------------------
Wendell Wierenga, Ph.D.


/s/ Harold R. Werner             Director                         March 6, 2002
--------------------
Harold R. Werner

                                 Director                         March 6, 2002
/s/ Gregory F. Zaic
-------------------
Gregory F. Zaic
</Table>
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          15,400
<SECURITIES>                                    22,195
<RECEIVABLES>                                    7,343
<ALLOWANCES>                                       298
<INVENTORY>                                      1,708
<CURRENT-ASSETS>                                48,939
<PP&E>                                           6,434
<DEPRECIATION>                                   3,744
<TOTAL-ASSETS>                                  77,036
<CURRENT-LIABILITIES>                            8,669
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            23
<OTHER-SE>                                      68,344
<TOTAL-LIABILITY-AND-EQUITY>                    77,036
<SALES>                                         30,632
<TOTAL-REVENUES>                                30,632
<CGS>                                            8,972
<TOTAL-COSTS>                                    8,972
<OTHER-EXPENSES>                                28,521
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             (1,037)
<INCOME-PRETAX>                                (5,824)
<INCOME-TAX>                                     3,533
<INCOME-CONTINUING>                            (9,357)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (9,357)
<EPS-BASIC>                                     (0.42)
<EPS-DILUTED>                                   (0.42)


</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### International Trade Commission

          - [WITC SC-01-024]

# AGENCY HOLDING THE MEETING:

United States International Trade Commission. 

# TIME AND DATE:

June 29, 2001 at 2:00 p.m. 

# PLACE:

Room 101, 500 E Street SW., Washington, DC 20436, Telephone: (202) 205-2000. 

# STATUS:

Open to the public. 

# MATTERS TO BE CONSIDERED:

 

1. Agenda for future meeting: none 

2. Minutes 

3. Ratification List 

4. Inv. Nos. 701-TA-415 and 731-TA-933-934 (Preliminary)(Polyethylene Terephthalate Film, Sheet, and Strip from India and Taiwan)—briefing and vote. (The Commission is currently scheduled to transmit its determination to the Secretary of Commerce on July 2, 2001; Commissioners' opinions are currently scheduled to be transmitted to the Secretary of Commerce July 10, 2001.) 

5. Outstanding action jackets: none 

In accordance with Commission policy, subject matter listed above, not disposed of at the scheduled meeting, may be carried over to the agenda of the following meeting. 

By order of the Commission.

Issued: June 13, 2001. 

Donna R. Koehnke, 

Secretary. 

[FR Doc. 01-15485 Filed 6-15-01; 12:19 pm] 

BILLING CODE 7020-02-P
SAN DIEGO NAVY BROADWAY COMPLEX COALITION, petitioner, v. DEPARTMENT OF DEFENSE, et al.

No. 16-503.

Supreme Court of the United States

Dec. 12, 2016.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
# C_2009220EN.01003105.xml

| 12.9.2009 | EN | Official Journal of the European Union | C 220/31 |
| --- | --- | --- | --- |

12.9.2009

EN

Official Journal of the European Union

C 220/31

---

Order of the President of the Court of 18 June 2009 — Commission of the European Communities v Portuguese Republic

(Case C–10/09) (1)

1

2009/C 220/64

Language of the case: Portuguese

Language of the case: Portuguese

The President of the Court has ordered that the case be removed from the register.

---

(1)  OJ C 55, 7.3.2009.

1

---
Commodity Futures Trading Commission 

 Office of Public Affairs 

 Three Lafayette Centre 

 1155 21st Street, NW 

 Washington, DC 20581 

 www.cftc.gov

Regulation 1.25 Q & A 

What is the goal of the proposed rulemaking? 

In proposing amendments to the Commission’s regulations regarding investment of customer and secured amount 

funds, the Commission seeks to simplify Regulation 1.25 and impose requirements that can better mitigate credit, 

liquidity and market risk and ensure the preservation of principal and maintenance of liquidity. The Commission 

proposes to (1) narrow the scope of investment choices; (2) raise certain standards imposed on permitted 

investments individually and on a portfolio basis, and (3) increase safety by promoting diversification. The 

Commission has endeavored to tailor its proposal to achieve these goals while retaining an appropriate degree of 

investment flexibility and opportunities for attaining capital efficiency for derivatives clearing organizations (DCOs) 

and futures commission merchants (FCMs) investing customer segregated funds and secured amount funds.

Does the proposal limit the collateral that may be used by customers of an FCM? 

No. This proposal focuses solely on the investment of customer funds by FCMs and DCOs. The Commission’s 

interest is in ensuring that customer funds are invested in instruments that satisfy the Commission’s overall 

objective of preserving principal and maintaining liquidity.

Does the proposal contain any amendments affecting investments money market mutual funds 

(MMMFs)? 

Yes. Investments in MMMFs would be subject to a 10% instrument-based concentration limit, meaning that an 

FCM or DCO may invest a maximum of 10% of its total assets in segregation in interests in MMMFs. Additionally, 

investments in MMMFs would be subject to a 2% issuer-based concentration limit, meaning that an FCM or DCO 

may invest a maximum of 2% of its total assets in segregation in any one family of funds. 

The proposal also contains two technical amendments. First, the rulemaking would clarify that acknowledgment 

letters for MMMFs are to be from a party that has substantial control over the fund’s assets and has sufficient 

knowledge and authority to facilitate redemption. Second, the rulemaking would update and clarify the next-day 

redemption requirement for MMMFs (as well as include an appendix with safe harbor language for MMMF 

prospectuses). 

Commodity Futures Trading Commission ♦ Office of Public Affairs ♦ 202-418-5080
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

          - [Docket No.  01N-0219]

# AGENCY:

Food and Drug Administration, HHS.

# ACTION: 

Notice.

# SUMMARY:

The Food and Drug Administration (FDA) is withdrawing, without prejudice, approval of a new drug application (NDA) for Breokinase® (Urokinase for Injection) held by Serono, Inc., 100 Longwater Circle, Norwell, MA 02061. Serono, Inc., notified the agency in writing that it does not intend to introduce Breokinase® into the U.S. market or export Breokinase® from the United States, and voluntarily requested that the approval of the application be withdrawn and thereby waived its opportunity for a hearing.

# DATES:

Effective July 23, 2001.

# FOR FURTHER INFORMATION CONTACT:

Michael D. Anderson, Center for Biologics Evaluation and Research (HFM-17), Food and Drug Administration, 1401 Rockville Pike, Rockville, MD  20852-1448, 301-827-6210.

# SUPPLEMENTARY INFORMATION:

                    In a letter to FDA dated October 10, 2000, Serono, Inc., voluntarily requested the withdrawal of NDA 17-873 for Breokinase® (Urokinase for Injection). Serono, Inc., neither intends to market the product in the United States nor export it from the United States.  The firm voluntarily requested that FDA withdraw NDA 17-873, and therefore has waived its opportunity for a hearing. In a December 13, 2000, letter to the firm, FDA acknowledged receipt of the request and stated it would proceed (to publish a                     **Federal Register**                     notice) withdrawing the NDA.                

Therefore, under section 505(e) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(e)) and under authority delegated to the Director, Center for Biologics Evaluation and Research (21 CFR 5.82), approval of the application listed in this document, and all amendments and supplements thereto, is hereby withdrawn, as of July 23, 2001.

Dated: May 18, 2001.

Kathryn C. Zoon,

Director, Center for Biologics Evaluation and Research.

[FR Doc. 01-15720 Filed 6-21-01; 8:45 am]

BILLING CODE 4160-01-S